Understanding supplements.
How do I evaluate what you're actually buying — in the nootropics aisle, the supplement industry's most exploitative territory?
The 'brain supplement' market sells hope to the frightened and ambition to the striving — and its signature products (proprietary 'focus blends,' racetam-adjacent gray-market chemicals, and caffeine-plus-theanine stacks at coffee-shop prices) share one unexamined question: does the molecule cross the blood-brain barrier, and has it shown anything in controlled trials? The honest shelf is narrow — a structural fat, a deficiency vitamin, and an energy buffer with real data. This chapter teaches the barrier question that filters the entire aisle.
DHA Softgels
With fat — the absorption rule
B12 Lozenges
Sublingual for bypass-dosing
Creatine Powder
5 g daily, unflavored
'Focus Blends'
The category this chapter filters
DHA-Forward Fish Oil
The brain-form ratio: DHA-dominant formulas serve the structural role (membranes), while EPA-dominant serve the mood role (our depression and omega-3 pages teach the split). This page's pick is DHA-forward by design. IFOS certification; with a fat-containing meal.
Algal DHA
The vegan route — and algal oils are naturally DHA-dominant, which serves the brain story. The original source (fish get their DHA from algae), delivered without the middlefish.
Choosing the Right Form & Dose
Label literacy in the nootropics aisle has four specific jobs:
- The barrier question first: any claimed brain-active ingredient owes a crossing story. DHA, B12, and creatine cross; most proprietary-blend darlings don't — or haven't shown it.
- DHA-forward vs EPA-forward: brain structure wants DHA; mood wants EPA (our depression page). Check which line dominates before buying for which purpose.
- B12 dose over form: 1,000 mcg oral (any form) corrects most deficiency; the sublingual route and the methyl-vs-cyano debate are refinements, not mechanisms.
- Creatine: monohydrate, 3–5 g, plain: the form-and-dose the entire evidence base used. The premium forms are the category's price trap.
- The standing rule: new cognitive symptoms are medical workup first — the shelf is the last stop, not the first.
Red Flags to Watch For
The brain-supplement market is the industry's most exploitative aisle. Be highly cautious of products that:
- Sell proprietary 'focus blends' — stacked ingredients at unlisted doses, none with controlled-trial support as a blend, aimed at the organ that regulates caution itself.
- Market gray-market 'nootropic' chemicals (racetams and successors) as supplements — unapproved drugs with thin safety data, sold to the optimizers.
- Claim to 'unlock 90% of your brain' — the 10%-myth in supplement form; there is no locked brain, and the claim marks the seller.
- Cite structural science for functional claims — 'DHA is the brain's fat' (true) does not mean capsules upgrade the built brain (unsupported). The is-ought fallacy, sold per bottle.